A spotlight on pathogenesis, interactions and novel therapeutic options in NAFLD

A spotlight on pathogenesis, interactions and novel therapeutic options in NAFLDA spotlight on pathogenesis, interactions and novel therapeutic options in NAFLD, Published online: 17 December 2018; doi:10.1038/s41575-018-0094-6In 2018, there have been substantial advances in our understanding of the risk factors for advanced liver disease in nonalcoholic fatty liver disease, including genetic variants and the gut microbiota. Promising results have also arisen from drugs targeting metabolic pathways involved in the progression of liver damage.
Source: Nature Reviews Gastroenterology and Hepatology - Category: Gastroenterology Authors: Source Type: research